ECSS
MRK icon

Eurizon Capital SGR SpA’s Merck MRK Stock Holding History

Eurizon Capital SGR SpA’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$309M Sell
2,398,834
-423,589
-15% -$49.6M 0.83% 23
2026
Q1 		$339M Buy
2,822,423
+311,350
+12% +$35.9M 1.06% 14
2025
Q4 		$265M Buy
+2,511,073
New +$236M 0.82% 17

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Eurizon Capital SGR SpA's MRK Position: Q2 2026 in Review

Eurizon Capital SGR SpA reduced its Merck (MRK) stake by 15% in Q2 2026, selling an estimated $49.6M and leaving 2,398,834 shares worth $309M. The position accounts for 0.83% of the portfolio, ranked #23.

Eurizon Capital SGR SpA first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $339M in Q1 2026. 3,816 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Eurizon Capital SGR SpA held 2,398,834 shares of Merck worth $309M as of Q2 2026.
  • Eurizon Capital SGR SpA sold 423,589 Merck shares in Q2 2026, an estimated $49.6M.
  • Merck made up 0.83% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #23 holding.
  • Eurizon Capital SGR SpA first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • Eurizon Capital SGR SpA's Merck position peaked at $339M in Q1 2026.
  • 3,816 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.